BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,132 | -2.5% | 7,006 | -3.2% | 0.00% | 0.0% |
| Q2 2023 | $780,766 | -44.1% | 7,234 | -35.5% | 0.00% | -57.1% |
| Q1 2023 | $1,397,551 | -31.6% | 11,219 | -17.5% | 0.01% | -36.4% |
| Q4 2022 | $2,043,443 | -2.7% | 13,603 | -12.6% | 0.01% | -8.3% |
| Q3 2022 | $2,100,000 | -35.8% | 15,568 | -29.1% | 0.01% | -36.8% |
| Q2 2022 | $3,273,000 | -43.6% | 21,954 | -35.5% | 0.02% | -34.5% |
| Q1 2022 | $5,807,000 | -20.2% | 34,046 | +20.2% | 0.03% | -17.1% |
| Q4 2021 | $7,278,000 | +116.5% | 28,332 | +130.1% | 0.04% | +94.4% |
| Q3 2021 | $3,361,000 | +5.6% | 12,312 | -13.0% | 0.02% | 0.0% |
| Q2 2021 | $3,184,000 | +20.9% | 14,155 | -41.3% | 0.02% | +12.5% |
| Q1 2021 | $2,633,000 | +35.2% | 24,118 | +0.9% | 0.02% | +33.3% |
| Q4 2020 | $1,948,000 | +25.7% | 23,896 | +6.7% | 0.01% | +9.1% |
| Q3 2020 | $1,550,000 | +3.6% | 22,395 | -0.1% | 0.01% | -15.4% |
| Q2 2020 | $1,496,000 | – | 22,415 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |